Clinical Trial Detail

NCT ID NCT01424982
Title Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic Leukemia
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

acute lymphoblastic leukemia

Therapies

Cytarabine + Methotrexate + Ponatinib

Rituximab

Ponatinib + Vincristine Sulfate

Cyclophosphamide + Dexamethasone + Doxorubicin + Vincristine Sulfate

Leucovorin

Age Groups: adult senior

No variant requirements are available.